Parity Associated with Long-Term Disease Progression in Women with Multiple Sclerosis (P02.130)

CONCLUSIONS: Our results indicate that parous women take a longer time to reach EDSS 6, compared to nulliparous women, suggesting a long term parity benefit. Further studies are necessary to clearly confirm this data as disease specifics may influence a patient to become or not pregnant.Disclosure: Dr. Teter has nothing to disclose. Dr. Kavak has nothing to disclose. Dr. Kolb has nothing to disclose. Dr. Zakalik has nothing to disclose. Dr. Weinstock-Guttman has received personal compensation for activities with Acorda Therapeutics, Biogen Idec, Serono Inc., Novartis, Pfizer, Inc., Teva Neuroscience and Genentech, Inc. as a speaker and/or participant on an advisory board. Dr. Weinstock-Guttman has received research support from the National Multiple Sclerosis Society, the National Institutes of Health, ITN, Teva Neuroscience, Biogen Idec, Serono Inc., Aspreva-Roche, Acorda Therapeutics & Cognition, Shire Pharmaceuticals Group and Novartis.

Source: Neurology - February 14, 2013 Category: Neurology Authors: Teter, B., Kavak, K., Kolb, C., Zakalik, K., Weinstock-Guttman, B. Tags: P02 Multiple Sclerosis: Pregnancy and Hormonal Influences Source Type: research